88 related articles for article (PubMed ID: 16578901)
1. New tests for AD.
Health News; 2006 Apr; 12(4):15. PubMed ID: 16578901
[No Abstract] [Full Text] [Related]
2. New tests for Alzheimer's disease.
Health News; 2006 Jun; 12(6):2. PubMed ID: 16826618
[No Abstract] [Full Text] [Related]
3. [Neurochemical early and differential diagnostics for Alzheimer's disease].
Wiltfang J; Lewczuk P; Maler M; Bleich S; Smirnov A; Kornhuber J
MMW Fortschr Med; 2004 Sep; 146(38):38-40. PubMed ID: 15532429
[TBL] [Abstract][Full Text] [Related]
4. The diagnosis of Alzheimer disease before it is Alzheimer dementia.
Frisoni GB; Padovani A; Wahlund LO
Arch Neurol; 2003 Jul; 60(7):1023; author reply 1023-4. PubMed ID: 12873864
[No Abstract] [Full Text] [Related]
5. [Alzheimer's disease as brain amyloidosis: diagnosis using cerebrospinal fluid abeta and tau].
Shoji M
Rinsho Byori; 2006 May; 54(5):503-8. PubMed ID: 16789421
[TBL] [Abstract][Full Text] [Related]
6. [Biological markers for diagnosis of Alzheimer's disease].
Takeda M; Tanaka T; Kudo T; Okochi M; Kamino A; Tagami S
Seishin Shinkeigaku Zasshi; 2004; 106(12):1610-4. PubMed ID: 15770965
[No Abstract] [Full Text] [Related]
7. [Biological markers for Alzheimer disease].
Tanaka T; Wada K; Yamamori H; Tanaka S; Kudo T; Takeda M
Seishin Shinkeigaku Zasshi; 2003; 105(4):387-92. PubMed ID: 12806899
[TBL] [Abstract][Full Text] [Related]
8. To tap or not to tap: cerebrospinal fluid biomarkers of Alzheimer's disease.
Growdon JH
Ann Neurol; 1998 Jul; 44(1):6-7. PubMed ID: 9667586
[No Abstract] [Full Text] [Related]
9. CSF biomarkers predict rate of cognitive decline in Alzheimer disease.
Kester MI; van der Vlies AE; Blankenstein MA; Pijnenburg YA; van Elk EJ; Scheltens P; van der Flier WM
Neurology; 2009 Oct; 73(17):1353-8. PubMed ID: 19858456
[TBL] [Abstract][Full Text] [Related]
10. [Biomarkers in cerebrospinal fluid and blood in memory complaints].
Zetterberg H; Andreasen N; Blennow K
Lakartidningen; 2009 May 13-19; 106(20):1386-9. PubMed ID: 19585836
[No Abstract] [Full Text] [Related]
11. CSF biomarkers in relationship to cognitive profiles in Alzheimer disease.
van der Vlies AE; Verwey NA; Bouwman FH; Blankenstein MA; Klein M; Scheltens P; van der Flier WM
Neurology; 2009 Mar; 72(12):1056-61. PubMed ID: 19307538
[TBL] [Abstract][Full Text] [Related]
12. Influence of delayed CSF storage on concentrations of phospho-tau protein (181), total tau protein and beta-amyloid (1-42).
Kaiser E; Schönknecht P; Thomann PA; Hunt A; Schröder J
Neurosci Lett; 2007 May; 417(2):193-5. PubMed ID: 17408854
[TBL] [Abstract][Full Text] [Related]
13. [Biological marker for Alzheimer's disease].
Matsubara E
Brain Nerve; 2010 Jul; 62(7):769-75. PubMed ID: 20675881
[TBL] [Abstract][Full Text] [Related]
14. CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment.
Stefani A; Martorana A; Bernardini S; Panella M; Mercati F; Orlacchio A; Pierantozzi M
J Neurol Sci; 2006 Dec; 251(1-2):124-8. PubMed ID: 17097109
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's biomarker initiative hits its stride.
Miller G
Science; 2009 Oct; 326(5951):386-9. PubMed ID: 19833956
[No Abstract] [Full Text] [Related]
16. CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease.
Schoonenboom NS; van der Flier WM; Blankenstein MA; Bouwman FH; Van Kamp GJ; Barkhof F; Scheltens P
Neurobiol Aging; 2008 May; 29(5):669-75. PubMed ID: 17208336
[TBL] [Abstract][Full Text] [Related]
17. Sugar chains of cerebrospinal fluid transferrin as a new biological marker of Alzheimer's disease.
Taniguchi M; Okayama Y; Hashimoto Y; Kitaura M; Jimbo D; Wakutani Y; Wada-Isoe K; Nakashima K; Akatsu H; Furukawa K; Arai H; Urakami K
Dement Geriatr Cogn Disord; 2008; 26(2):117-22. PubMed ID: 18654083
[TBL] [Abstract][Full Text] [Related]
18. Concentrations of metals, beta-amyloid and tau-markers in cerebrospinal fluid in patients with Alzheimer's disease.
Gerhardsson L; Blennow K; Lundh T; Londos E; Minthon L
Dement Geriatr Cogn Disord; 2009; 28(1):88-94. PubMed ID: 19672066
[TBL] [Abstract][Full Text] [Related]
19. Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI.
Nordlund A; Rolstad S; Klang O; Lind K; Pedersen M; Blennow K; Edman A; Hansen S; Wallin A
J Int Neuropsychol Soc; 2008 Jul; 14(4):582-90. PubMed ID: 18577287
[TBL] [Abstract][Full Text] [Related]
20. Elevated CNS concentrations of NFL in idiopathic normal pressure hydrocephalus (INPH) and subcortical arteriosclerotic encephalopathy (SAE).
Jellinger KA; Rösler N
Acta Neurol Scand; 2008 Jun; 117(6):435. PubMed ID: 18307570
[No Abstract] [Full Text] [Related]
[Next] [New Search]
